跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39 条关于
“Epkin”
全部
39
临床试验
3
药物
1
机构
1
资讯
34
去年
Owkin Launches ATLANTIS: AI-Powered Patient Data Mining Initiative Across 20 Global Healthcare Centers
去年
Genmab's Epkinly Achieves 79% Reduction in Disease Progression Risk in Phase III Follicular Lymphoma Trial
10个月前
FDA Approves AbbVie and Genmab's Epkinly for Relapsed or Refractory Follicular Lymphoma
去年
Regeneron's Ordspono Shows Promise in Relapsed/Refractory Marginal Zone Lymphoma
2年前
FDA Approves Epkinly (epcoritamab-bysp) for Relapsed/Refractory Follicular Lymphoma
去年
AstraZeneca's AZD0486 Shows Promise in Relapsed/Refractory Follicular Lymphoma
10个月前
Five Major FDA Decisions Expected in November 2025 Across Cancer, Rare Disease, and Genetic Disorders
8个月前
Genmab Discontinues Acasunlimab Development to Focus on Late-Stage Pipeline Programs
10个月前
FDA Approves First Bispecific Antibody Combination for Relapsed/Refractory Follicular Lymphoma
9个月前
Genmab Discontinues Phase III Lung Cancer Bispecific Antibody Acasunlimab to Focus on Late-Stage Pipeline
第 1 页,共 4 页
上一页
下一页